ELI LILLY AND COMPANY

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 500 24
 
 
C07D HETEROCYCLIC COMPOUNDS 313 18
 
 
C07K PEPTIDES 111 41
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 61 85
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 58 39
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 44 120
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 40 89
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 37 64
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 32 20
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 29 67
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0156,371 ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS Feb 17, 17 Jun 08, 17 [C12N, A23K, A61K]
2017/0112,904 GLUCAGON RECEPTOR AGONISTS Oct 14, 16 Apr 27, 17 [A61K, C07K]
2017/0095,613 ROTATABLE END OF DOSE FEEDBACK MECHANISM Jun 04, 15 Apr 06, 17 [A61M]
2017/0073,403 CGRP ANTIBODIES Nov 02, 16 Mar 16, 17 [C07K]
2017/0066,780 INHIBITORS OF EZH2 Aug 22, 16 Mar 09, 17 [C07D, A61K]
2017/0056,478 RAPID-ACTING INSULIN COMPOSITIONS Aug 19, 16 Mar 02, 17 [A61K]
2017/0044,138 CGRP RECEPTOR ANTAGONISTS Aug 05, 16 Feb 16, 17 [C07D, C07C]
2016/0368,922 2-OXO-1,3,8-TRIAZASPIRO[4.5]DECAN-3-YL] CARBOXYLIC ACID DERIVATIVES Jun 08, 16 Dec 22, 16 [C07D]
2016/0368,960 GLUCAGON AND GLP-1 CO-AGONIST COMPOUNDS Jun 16, 16 Dec 22, 16 [C07K]
2016/0369,004 ANTI-MET IN COMBINATION WITH ANTI-VEGFR2 ANTIBODIES THERAPY FOR CANCER Feb 25, 15 Dec 22, 16 [A61K, C07K]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9670284 Therapeutic uses for VEGFR1 antibodies Mar 11, 14 Jun 06, 17 [A61K, C07K]
9644014 Modified animal erythropoietin polypeptides and their uses Sep 15, 15 May 09, 17 [C12N, A61K, C07K]
9637474 Aurora A kinase inhibitor Nov 06, 15 May 02, 17 [C07D]
9637495 CGRP receptor antagonists Aug 05, 16 May 02, 17 [C07D, C07C]
9624218 Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors Oct 29, 14 Apr 18, 17 [C07D, A61P, A61K]
9617243 Aminopyridyloxypyrazole compounds Sep 30, 15 Apr 11, 17 [C07D]
9617263 Phenyl-triazolo-pyridine compounds Jan 06, 15 Apr 11, 17 [C07D, A61K]
9617285 1-hydroxy-benzooxaboroles as antiparasitic agents Mar 06, 14 Apr 11, 17 [A01N, C07F]
9604967 Azetidinyloxyphenylpyrrolidine compounds Jan 15, 16 Mar 28, 17 [C07D, A61K]
9598431 Compounds useful for inhibiting ROR-gamma-t Sep 06, 16 Mar 21, 17 [C07D, A61K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0376,178 Pyridinoylpiperidines As 5-HT1F Agonists ABAN Jun 05, 14 Dec 31, 15 [C07D]
2015/0322,083 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS SELECTIVE 5-HT2A INVERSE AGONISTS ABAN Apr 22, 15 Nov 12, 15 [C07D]
2015/0258,177 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA ABAN Jun 02, 15 Sep 17, 15 [A61K]
2015/0203,471 METHODS FOR IMPROVING CHICKEN PRODUCTION ABAN Sep 24, 13 Jul 23, 15 [C07D, C07C, A23K]
2015/0183,877 Multi-Specific IgG-(Fab)2 Constructs Containing T-Cell Receptor Constant Domains ABAN Jul 15, 13 Jul 02, 15 [C07K]
2015/0152,158 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Feb 10, 15 Jun 04, 15 [C07K]
2015/0141,335 THERAPEUTIC USES OF FIBROBLAST GROWTH FACTOR 21 PROTEINS ABAN May 09, 13 May 21, 15 [A61K]
2015/0045,313 Ectoparasiticidal Methods and Formulations ABAN Oct 28, 14 Feb 12, 15 [A01N]
2014/0271,671 RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR ABAN Mar 14, 13 Sep 18, 14 [C12Q]
2014/0275,049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS ABAN Oct 19, 12 Sep 18, 14 [C07D, A61K]
2014/0206,613 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Mar 31, 14 Jul 24, 14 [C07K]
2014/0206,877 NOVEL INTERMEDIATE AND PROCESS USEFUL IN THE PREPARATION OF -(2-CHLOROPHENYL)-METHANONE ABAN Mar 27, 14 Jul 24, 14 [C07D]
2014/0171,497 ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR ABAN Jul 26, 12 Jun 19, 14 [A23K, A61K]
2014/0163,097 ANIMAL SUPPLEMENTS AND FOOD COMPOSITIONS CONTAINING SOLUBLE MONENSIN COMPOSITION, AND METHODS AND PROCESSES THEREFOR ABAN Jul 26, 12 Jun 12, 14 [A23K, A61K]
2014/0056,893 Homodimeric Proteins ABAN Aug 15, 13 Feb 27, 14 [C07K]
2014/0050,763 MODIFIED VIRAL PARTICLES WITH IMMUNOGENIC PROPERTIES AND REDUCED LIPID CONTENT USEFUL FOR TREATING AND PREVENTING INFECTIOUS DISEASES ABAN Oct 30, 13 Feb 20, 14 [A61K]
2014/0024,586 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY ABAN Oct 03, 13 Jan 23, 14 [A61K]
2013/0228,136 LIQUID DISPENSER ABAN Apr 17, 13 Sep 05, 13 [A01K]
2013/0210,755 METHODS FOR INHIBITING INSECT INFESTATIONS ABAN Nov 07, 11 Aug 15, 13 [A01N, A61K]
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Sep 14, 12 Jan 24, 13 [A61P, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
ELI LILLY AND COMPANY
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL